The purpose of this study is to evaluate the long-term durability of the treatment and safety of the Provent device for those individuals who were enrolled in the C009 study, were diagnosed with obstructive sleep apnea-hypopnea (OSAH), and were actively using the Provent device.
Study Type
OBSERVATIONAL
Enrollment
65
Gaylord Sleep Medicine Research
Wallingford, Connecticut, United States
University of Florida Health Science Center
Gainesville, Florida, United States
Sleep Disorders Center of Georgia
Atlanta, Georgia, United States
To measure the percent change in the subject's apnea-hypopnea index (AHI) during the 12 month PSG while wearing the Provent device as compared to their AHI during the first week PSG when the subject did not wear the Provent device in the C009 study
Time frame: 12 months
Measurement of the subjects quality of life
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Suburban Lung Associates
Elk Grove Village, Illinois, United States
Kentucky Research Group
Louisville, Kentucky, United States
Sleep HealthCenters
Brighton, Massachusetts, United States
Wayne State University Harper Univ. Hospital
Detroit, Michigan, United States
Borgess Research
Kalamazoo, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
St. Luke's Hospital Sleep Medicine & Research Center
Chesterfield, Missouri, United States
...and 3 more locations